Listex is a technology company that does not distribute products, that's why there is no opportunity to buy or sell any goods on this site.

Tums Ultra Strength 1000 Antacid Tablets Peppermint - 12 CT
Tums Ultra Strength 1000 Antacid Tablets Peppermint - 12 CT
Tums Ultra Strength 1000 Antacid Tablets Peppermint - 12 CT
Tums Ultra Strength 1000 Antacid Tablets Peppermint - 12 CT
Tums Ultra Strength 1000 Antacid Tablets Peppermint - 12 CT
Tums Ultra Strength 1000 Antacid Tablets Peppermint - 12 CT
Tums Ultra Strength 1000 Antacid Tablets Peppermint - 12 CT
Tums Ultra Strength 1000 Antacid Tablets Peppermint - 12 CT
The product has not been verified
Product information may be out of date
Product barcodes

Characteristics Tums Ultra Strength 1000 Antacid Tablets Peppermint - 12 CT.

ItemMaster Dimensions
Length, IN 0.77
Height, IN 0.77
Width, IN 2.74
Weight, LB 0.07
special attributes
Units In Package 12
Package Type ROLL
Package Size, CT 12.0
Net Weight, OZ 1.1
Seasonal N
Ingredients Active Ingredients (per tablet) - Purpose: Calcium Carbonate USP 1000mg - Antacid. Inactive Ingredients: Corn Starch, Mineral Oil, Natural Flavor, Sodium Polyphosphate, Sucrose, Talc.
Gluten Free Y
Temperature Indicator Shelf Stable
Directions Chew 2-3 tablets as symptoms occur, or as directed by a doctor. Other information: Each tablet contains: Elemental calcium 400mg, sodium 2mg. Store below 30 degrees C (86 degrees F).
Marketing Description Tums® Ultra Strength 1000 Antacid Tablets with Calcium Peppermint.
Other Description Uses: Relieves. Heartburn. Sour Stomach. Acid indigestion. Gluten-free. Question? 1-800-897-7535 weekdays. ©2009 GlaxoSmithKline.
Ecommerce Description Tums® Ultra Strength 1000 Antacid Tablets Peppermint. It relieves from heartburn, sour stomach and acid indigestion. It is gluten free product.
Reviews and questions about Tums Ultra Strength 1000 Antacid Tablets Peppermint - 12 CT
Log in to leave a review:
Subscribe to new reviews
Subscribe to new reviews
Further instructions are sent to the specified Email
Subscribe to the newsletter